Latest Lead News

CLINUVEL Pharmaceuticals is preparing to elevate its American Depository Receipt program to a Nasdaq Level II listing by the end of 2025, aiming to enhance visibility and trading access in the U.S. without altering its primary ASX listing.

Viridis Mining and Minerals has significantly expanded its Colossus Rare Earth Elements project in Brazil, securing an additional 2,503.6 hectares adjacent to its existing licenses. This move, backed by robust government support and strategic partnerships, enhances the project's scale and de-risks its pathway to production.

LTR Pharma has announced that its erectile dysfunction treatment SPONTAN now boasts an 18-month shelf life, surpassing commercial standards and paving the way for international market growth.

Coast Entertainment Holdings reports its strongest financial year since 2016, driven by a surge in ticket sales and new attractions, while FY26 begins with robust growth and strategic initiatives.

Cobram Estate Olives Limited has reported record financial results for FY2025, driven by strong sales growth in Australia and a doubling of branded sales in the USA. The company is shifting its capital expenditure focus to expand its Californian operations while maintaining sustainable growth in Australia.

Boom Logistics reported solid FY25 results with a 41% jump in operating profit, driven by strong contract wins in resources and renewables and a strategic asset regeneration program.

Inghams Group reported a stable FY25 underlying EBITDA pre AASB 16 at $236.4 million, with strong New Zealand growth offsetting challenges in Australia. The company outlines a cautious but optimistic FY26 outlook, focusing on cost reductions and operational efficiencies.

Guzman y Gomez (GYG) has reported record FY25 results, surpassing $1.18 billion in global network sales and delivering a 45.5% increase in EBITDA. The company also declared its maiden fully-franked dividend, signaling confidence in sustained growth.

Arovella Therapeutics reported a 14% reduction in net loss to $7.5 million for FY25, bolstered by a $15 million capital raise to fund its lead iNKT cell therapy program progressing toward a pivotal phase 1 clinical trial.

Altamin Limited announces a significant board and executive reshuffle, appointing Peter Edwards as non-executive Chairman and Geraint Harris as incoming CEO, signaling a renewed focus on critical raw materials for Europe’s energy transition.

Latitude Group Holdings Limited reported robust half-year results with record new loan originations, expanding receivables, and improved margins, underpinned by strong operational execution and funding strategies.

BSP Financial Group Limited has reported a robust half-year performance for 1H25, marked by nearly 10% growth in revenue and net profit after tax, alongside a healthy capital position and an increased interim dividend.